The US Dollar has frustrated the majority of market participants this year, particularly if they're only looking at the US Dollar Index.
With that said, we've been focused on other US Dollar pairs that aren't getting much attention but are trending well and providing us with plenty of opportunities.
We've been writing about the lack of trend in the Major Indices and highlighting some relative strength in places like Software and Insurance, but overall signals remain mixed.
This morning I set out to write another post about areas showing relative strength, hoping to find a clean theme that the most actionable stock setups fit within.
What I found can be boiled down to the length of two tweets.
"Going through the S&P 1500 I see a number of actionable names on the long side, but they don't all fit a theme. They're all from different areas of the market. Where there are themes I see a lot of extended names and unattractive entries."
and
"I can see that the path of least resistance is higher in a lot of names, but that doesn't mean that current levels offer an attractive entry."
Last week I sat down with Justine Underhill for Real Vision's "Trade Ideas" show to discuss a tactical trading opportunity in Palladium and a longer-term play in the Insurance industry.
These are themes I've shared with our Institutional Clients over the last few weeks. I hope you find some value in them.
Wednesday's Mystery Chart is one of my favorite charts, so thank you everyone for your feedback and participation.
I received a lot of answers, but most of you were buyers of this recent pullback, while others were waiting to see if prices reacted positively to support before jumping in. Not many of you were sellers.
Monday was our Members-Only Conference Call for both India and the US (see JC's video here) and the most overwhelming theme was that Equities are not trending, so what does that mean for us as market participants?
Twice a year the Nifty Indexes are reconstituted on March 31 and September 30, replacing stocks that don't fit the criteria with those that do. This past weekend we adjusted our chartbooks to reflect the changes that occurred at the end of the first quarter, so I wanted to write a quick post detailing some of the changes.
For those new to the exercise, we take a chart of interest and remove the x/y-axes and any other labels that would help identify it. The chart can be any security in any asset class on any timeframe on an absolute or relative basis. It can even be inverted or a custom index.
The point here is to not guess what it is, but instead think about what you would do right now.Buy,Sell, or Do Nothing?
Every few weeks I get a message from someone asking a question along the lines of "Should I enroll in the CMT Program?" As with most things, the answer is it depends on your individual situation.
While I can't offer personalized advice to everyone, I can discuss my experience and the key benefits now that I've completed the process.
This post is going to be split into two parts; one where I explain my answer to the question that prompted this post, and the other where I summarize my actual experience in the program.
Wednesday's Mystery Chart is one of my favorite right now, so thank you everyone for your feedback and participation.
I received a lot of answers, but most of you were skeptical of the breakout and wanted to see more before getting involved. A few others wanted to be long with a tight stop and few, if any, were sellers.
With that as our backdrop, let's get into it.
The actual chart was the ratio of the Insurance subsector ($IAK) relative to the S&P 500, which is breaking out to 11-month highs as momentum gets overbought for the first time in nearly 2 years.
To me this looks like a textbook trend reversal, so while there may be some backing and filling over the near-term, Insurance stocks look set to outperform over the intermediate/long-term.
About eight months ago Patrick Dunuwila from The Chart Report introduced me to a new data visualization platform called Koyfin. Two month's later I met Rob, one of the co-founders, at Stocktoberfest West. He walked me through the product and what they were doing and I was sold.
A few months later we had the opportunity to invest and we jumped at it. We loved the product and the team, so it seemed like a natural fit.
Today, Koyfin is an irreplaceable tool that I use alongside Optuma as my main tools for charting and analysis.
I get a lot of questions about how I use it, so I wanted to write a post answering just that.